Waltham, MA-based Dynogen announced today that it will go public in a reverse merger with a subsidiary of California's Apex Bioventures.
42103
Dynogen goes public via reverse merger
113210
Biogen Idec to report fourth quarter and year end 2010 financial results on February 1, 2011
14659
Orange and T-mobile to merge
72240
Lundbeck to acquire Ovation Pharmaceuticals
95911
Sanofi-Aventis to acquire Genzyme?
43090
Boston Scientific to acquire BridgePoint Medical
68249
Anesiva moves closer to merger
140505
StockerYale changes name to ProPhotonix
22291
DTS to acquire SRS Labs
163968
Shine.com to be merged into HT Media
41423
Dainippon Sumitomo Pharma to buy US bio-venture
22250
Kraft Foods to split into two separate companies
140704
Amgen licenses molecule for the treatment of chronic and neuropathic pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc.
86256
Continental and United announce merger;
12617
Alchemia to spin off oncology business
66708
Danaher Corporation and Cooper Industries announce sale of Apex Tool Group to Bain Capital;
29824
Cuningham Group expands to San Diego and Phoenix with acquisition